• Please log in or register to access this feature.

Perspective

You have free access to this content

Uncertainties in the prevention and treatment of glucocorticoid-induced osteoporosis†

  1. Karen E Hansen1,*,
  2. H Alexander Wilson2,
  3. Carol Zapalowski3,
  4. Howard A Fink4,
  5. Salvatore Minisola5,
  6. Robert A Adler6,7

Article first published online: 30 JUN 2011

DOI: 10.1002/jbmr.362

Issue

Journal of Bone and Mineral Research

Journal of Bone and Mineral Research

Volume 26, Issue 9, pages 1989–1996, September 2011

Additional Information

How to Cite

Hansen, K. E., Wilson, H. A., Zapalowski, C., Fink, H. A., Minisola, S. and Adler, R. A. (2011), Uncertainties in the prevention and treatment of glucocorticoid-induced osteoporosis. J Bone Miner Res, 26: 1989–1996. doi: 10.1002/jbmr.362

Author Information

  1. 1

    University of Wisconsin Department of Medicine, Madison, WI, USA

  2. 2

    The Bone Health Center, Newport News, VA, USA

  3. 3

    Denver Center for Bone Health, Denver, CO, USA

  4. 4

    Geriatrics Research Education and Clinical Center, Veterans Affairs Medical Center, Minneapolis, MN, USA

  5. 5

    “Sapienza,” University of Rome, Rome, Italy

  6. 6

    Endocrinology and Metabolism Section, McGuire Veterans Affairs Medical Center, Richmond, VA, USA

  7. 7

    Departments of Medicine and Epidemiology, Virginia Commonwealth University School of Medicine, Richmond, VA, USA

*Room 4124 MFCB, 1685 Highland Avenue, Madison, WI 53705-2281, USA.

  1. †

    This document was prepared on behalf of the Professional Practice Committee of the American Society for Bone and Mineral Research.

Publication History

  1. Issue published online: 19 AUG 2011
  2. Article first published online: 30 JUN 2011
  3. Manuscript Accepted: 3 FEB 2011
  4. Manuscript Revised: 18 JAN 2011
  5. Manuscript Received: 18 NOV 2010

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (96K)

Abstract

Much knowledge has accrued since the 2001 American College of Rheumatology (ACR) guidelines were published to assist clinicians in the prevention and treatment of glucocorticoid-induced osteoporosis (GIO). Therefore, the ACR undertook a comprehensive effort to review the literature and update the GIO guidelines [Grossman JM, Gordon R, Ranganath VK, et al. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken). 2010;62:1515–1526]. Herein, we review the new guidelines for JBMR readers, highlighting the changes introduced by the 2010 publication. We discuss several patient scenarios for which the new treatment guidelines do not apply, or for which our committee interprets existing literature differently and suggests an alternative approach. © 2011 American Society for Bone and Mineral Research

View Full Article with Supporting Information (HTML) Get PDF (96K)